BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34549602)

  • 21. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
    Zanella AB; Scheffel RS; Nava CF; Golbert L; Laurini de Souza Meyer E; Punales M; Gonçalves I; Dora JM; Maia AL
    Thyroid; 2018 Oct; 28(10):1285-1292. PubMed ID: 30129889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric differentiated thyroid carcinoma: The clinicopathological features and the coexistence of Hashimoto's thyroiditis.
    Ren PY; Liu J; Xue S; Chen G
    Asian J Surg; 2019 Jan; 42(1):112-119. PubMed ID: 29254871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents.
    Papendieck P; Gruñeiro-Papendieck L; Venara M; Acha O; Maglio S; Bergadá I; Chiesa A
    J Pediatr Endocrinol Metab; 2011; 24(9-10):743-8. PubMed ID: 22145467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of presentation and clinical outcome between children and young adults with differentiated thyroid cancer.
    Wang JT; Huang R; Kuang AR
    Asian Pac J Cancer Prev; 2014; 15(17):7271-5. PubMed ID: 25227827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clinical outcomes in differentiated thyroid carcinoma between children and young adult patients.
    Kim SS; Kim SJ; Kim IJ; Kim BH; Jeon YK; Kim YK
    Clin Nucl Med; 2012 Sep; 37(9):850-3. PubMed ID: 22889773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?
    Goffredo P; Roman SA; Sosa JA
    Thyroid; 2014 Mar; 24(3):463-71. PubMed ID: 23978295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
    Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
    Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA
    Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Outcomes and Prognoses of Elderly Patients (≥65-Years-Old) With Distant Metastases From Well-Differentiated Thyroid Cancer During Radioiodine Therapy and Follow-Up.
    Qiu ZL; Shen CT; Sun ZK; Song HJ; Xi C; Zhang GQ; Wang Y; Luo QY
    Front Endocrinol (Lausanne); 2020; 11():588024. PubMed ID: 33716950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.
    Tam S; Amit M; Boonsripitayanon M; Busaidy NL; Cabanillas ME; Waguespack SG; Gross ND; Grubbs EG; Williams MD; Lai SY; Sturgis EM; Zafereo ME
    Thyroid; 2018 Aug; 28(8):982-990. PubMed ID: 29936892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure.
    Wang LY; Ghossein R; Palmer FL; Nixon IJ; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
    Thyroid; 2015 Sep; 25(9):993-8. PubMed ID: 26122000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 34. Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.
    Jain NK; Mostoufi-Moab S; Hawkes CP; Nelson ND; Surrey LF; Jones ZS; Adzick NS; Kazahaya K; Bauer AJ
    Thyroid; 2020 Jul; 30(7):1037-1043. PubMed ID: 31573414
    [No Abstract]   [Full Text] [Related]  

  • 35. Disease Burden and Outcome in Children and Young Adults With Concurrent Graves Disease and Differentiated Thyroid Carcinoma.
    MacFarland SP; Bauer AJ; Adzick NS; Surrey LF; Noyes J; Kazahaya K; Mostoufi-Moab S
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2918-2925. PubMed ID: 29788090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.
    Slook O; Levy S; Slutzky-Shraga I; Tsvetov G; Robenshtok E; Shimon I; Benbassat C; Hirsch D
    Endocr Pract; 2019 May; 25(5):427-437. PubMed ID: 30657361
    [No Abstract]   [Full Text] [Related]  

  • 37. Benefits and harms of hemithyroidectomy, total or near-total thyroidectomy in 1-4 cm differentiated thyroid cancer.
    Xu Y; Huang K; Huang P; Ke N; Zeng J; Wang L; Liu C; Shi X; Guo F; Su L; Lin M; Li X; Xiao F
    Clin Endocrinol (Oxf); 2021 Oct; 95(4):668-676. PubMed ID: 33948971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
    Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
    [No Abstract]   [Full Text] [Related]  

  • 39. Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
    Robenshtok E; Nachalon Y; Benbassat C; Hirsch D; Shimon I; Grossman A; Diker-Cohen T; Akirov A; Popovtzer A
    Thyroid; 2017 Sep; 27(9):1171-1176. PubMed ID: 28791923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.